• 1
    Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. New Engl J Med 1997; 337: 441446.
  • 2
    Hay AD, Thomas M, Montgomery A et al. The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data. J Antimicrob Chemother 2005; 56: 146153.
  • 3
    Goossens H, Ferech M, Vander SR, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579587.
  • 4
    Filippini M, Masiero G, Moschetti K. Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy 2006; 78: 7792.
  • 5
    Briel M, Young J, Tschudi P et al. Prevalence and influence of diagnostic tests for acute respiratory tract infections in primary care. Swiss Med Wkly 2006; 136: 248253.
  • 6
    Briel M, Schuetz P, Mueller B et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008; 168: 20002007.
  • 7
    Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 2009; 338: b1374.
  • 8
    e-mediat AG. Artikelstamm über Informationssysteme im Gesundheitswesen Galdat. Bern, Switzerland, 2009. Available at: (last accessed 30 June 2010).
  • 9
    World Health Organisation. WHO Collaborating Centre for Drug Statistics Methodology. The anatomical therapeutic chemical (ATC) and defined daily dosing (DDD) system. Oslo, Norway, 2009. Available at: (last accessed 30 June 2010).
  • 10
    Federal Statistic Office. Altersmasszahlen der ständigen Wohnbevölkerung nach Staatsangehörigkeit und Geschlecht, 2007. Bern, Switzerland, 2009. Available at: (last accessed 30 June 2010).
  • 11
    Federal Statistic Office. Die 7 Grossregionen der Schweiz. 2010. Available at: (last accessed 30 June 2010).
  • 12
    Gemeinsame Einrichtung Krankenversicherungsgesetz (KVG). Statistik definitiver Risikoausgleich 2007. Solothurn, Switzerland, 2009. Available at: (last accessed 30 March 2010).
  • 13
    Besser RE. Antimicrobial prescribing in the United States: good news, bad news. Ann Intern Med 2003; 138: 605606.
  • 14
    Klugman KP, Lonks JR. Hidden epidemic of macrolide-resistant pneumococci. Emerg Infect Dis 2005; 11: 802807.
  • 15
    Hyde TB, Gay K, Stephens DS et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 2001; 286: 18571862.
  • 16
    Elseviers MM, Ferech M, Vander Stichele RH, Goossens H. Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf 2007; 16: 115123.
  • 17
    Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 18511853.
  • 18
    Welschen I, Kuyvenhoven M, Hoes A, Verheij T. Antibiotics for acute respiratory tract symptoms: patients’ expectations, GPs’ management and patient satisfaction. Fam Pract 2004; 21: 234237.
  • 19
    Little P, Dorward M, Warner G, Stephens K, Senior J, Moore M. Importance of patient pressure and perceived pressure and perceived medical need for investigations, referral, and prescribing in primary care: nested observational study. BMJ 2004; 328: 444.
  • 20
    Andre M, Schwan A, Odenholt I. The use of CRP tests in patients with respiratory tract infections in primary care in Sweden can be questioned. Scand J Infect Dis 2004; 36: 192197.
  • 21
    Bjerrum L, Gahrn-Hansen B, Munck AP. C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis. Br J Gen Pract 2004; 54: 659662.
  • 22
    Bossuyt PM, Lijmer JG, Mol BW. Randomised comparisons of medical tests: sometimes invalid, not always efficient. Lancet 2000; 356: 18441847.
  • 23
    Dahler-Eriksen BS, Lauritzen T, Lassen JF, Lund ED, Brandslund I. Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. Clin Chem 1999; 45: 478485.
  • 24
    Diederichsen HZ, Skamling M, Diederichsen A et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scand J Prim Health Care 2000; 18: 3943.
  • 25
    Gonzales R, Aagaard EM, Camargo CA Jr. et al. C-reactive protein testing does not decrease antibiotic use for acute cough illness when compared to a clinical algorithm. J Emerg Med 2008; doi: 10.1016/j.jemermed.2008.06.021.
  • 26
    Achermann R. Abrechnungseffekte bei der Umstellung von Tiers Garant (TG) zu Tiers Payant (TP). HelsanaIS, ed. 2006.
  • 27
    Engstrom S, Molstad S, Lindstrom K, Nilsson G, Borgquist L. Excessive use of rapid tests in respiratory tract infections in Swedish primary health care. Scand J Infect Dis 2004; 36: 213218.